24 related articles for article (PubMed ID: 30606)
1. Redox Imbalance and Oxidative DNA Damage During Isoniazid Treatment of HIV-Associated Tuberculosis: A Clinical and Translational Pharmacokinetic Study.
Zentner I; Back HM; Kagan L; Subbian S; Nagajyothi J; Srivastava S; Pasipanodya J; Gumbo T; Bisson GP; Vinnard C
Front Pharmacol; 2020; 11():1103. PubMed ID: 32848735
[TBL] [Abstract][Full Text] [Related]
2. Human Cytochrome P450 1, 2, 3 Families as Pharmacogenes with Emphases on Their Antimalarial and Antituberculosis Drugs and Prevalent African Alleles.
Chamboko CR; Veldman W; Tata RB; Schoeberl B; Tastan Bishop Ö
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834793
[TBL] [Abstract][Full Text] [Related]
3. Increased urinary excretion of toxic hydrazino metabolites of isoniazid by slow acetylators. Effect of a slow-release preparation of isoniazid.
Peretti E; Karlaganis G; Lauterburg BH
Eur J Clin Pharmacol; 1987; 33(3):283-6. PubMed ID: 3691615
[TBL] [Abstract][Full Text] [Related]
4. Proton NMR spectroscopic studies on the metabolism and biochemical effects of hydrazine in vivo.
Sanins SM; Timbrell JA; Elcombe C; Nicholson JK
Arch Toxicol; 1992; 66(7):489-95. PubMed ID: 1332653
[TBL] [Abstract][Full Text] [Related]
5. Studies on the effects of isoniazid on acetylhydrazine metabolism in vivo and in vitro.
Timbrell JA; Wright JM
Drug Metab Dispos; 1979; 7(4):237-40. PubMed ID: 39727
[TBL] [Abstract][Full Text] [Related]
6. Acetylation of acetylhydrazine, the toxic metabolite of isoniazid, in humans. Inhibition by concomitant administration of isoniazid.
Peretti E; Karlaganis G; Lauterburg BH
J Pharmacol Exp Ther; 1987 Nov; 243(2):686-9. PubMed ID: 3681700
[TBL] [Abstract][Full Text] [Related]
7. Oxidation of hydrazine metabolites formed from isoniazid.
Lauterburg BH; Smith CV; Todd EL; Mitchell JR
Clin Pharmacol Ther; 1985 Nov; 38(5):566-71. PubMed ID: 3931954
[TBL] [Abstract][Full Text] [Related]
8. Monoacetylhydrazine as a metabolite of isoniazid in man.
Timbrell JA; Wright JM; Baillie TA
Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):602-8. PubMed ID: 913027
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of [14C]acetylisoniazid and [14C]acetylhydrazine by the rat and rabbit.
Thomas BH; Whitehouse LW; Zeitz W
Fundam Appl Toxicol; 1984 Aug; 4(4):646-53. PubMed ID: 6479511
[TBL] [Abstract][Full Text] [Related]
10. Factors affecting the metabolism of [14C]acetylhydrazine in rats.
Wright JM; Timbrell JA
Drug Metab Dispos; 1978; 6(5):561-6. PubMed ID: 30606
[TBL] [Abstract][Full Text] [Related]
11. Isoniazid metabolism and hepatotoxicity.
Wang P; Pradhan K; Zhong XB; Ma X
Acta Pharm Sin B; 2016 Sep; 6(5):384-392. PubMed ID: 27709007
[TBL] [Abstract][Full Text] [Related]
12. The role of metabolism in the hepatotoxicity of isoniazid and iproniazid.
Timbrell JA
Drug Metab Rev; 1979; 10(1):125-47. PubMed ID: 393481
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
